Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS.

Blood. 2009 Nov 26;114(23):4886-96. doi: 10.1182/blood-2009-06-228940. Epub 2009 Oct 1.

2.

Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Abou-Saleh RH, Connell SD, Harrand R, Ajjan RA, Mosesson MW, Smith DA, Grant PJ, Ariëns RA.

Biophys J. 2009 Mar 18;96(6):2415-27. doi: 10.1016/j.bpj.2008.12.3913.

3.

Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player.

Vestweber D, Winderlich M, Cagna G, Nottebaum AF.

Trends Cell Biol. 2009 Jan;19(1):8-15. doi: 10.1016/j.tcb.2008.10.001. Epub 2008 Nov 17. Review.

PMID:
19010680
4.

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group.

Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30.

PMID:
18976247
5.

Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.

Campbell RA, Overmyer KA, Bagnell CR, Wolberg AS.

Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2247-54. doi: 10.1161/ATVBAHA.108.176008. Epub 2008 Oct 30.

6.

Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.

Hill M, Dolan G.

Haemophilia. 2008 Sep;14(5):889-97. doi: 10.1111/j.1365-2516.2008.01795.x. Epub 2008 Jun 28. Review.

PMID:
18564189
7.

Which knobs fit into which holes in fibrin polymerization?

Weisel JW.

J Thromb Haemost. 2007 Dec;5(12):2340-3. Epub 2007 Oct 8. No abstract available.

8.

Fibrin structure and wound healing.

Laurens N, Koolwijk P, de Maat MP.

J Thromb Haemost. 2006 May;4(5):932-9. Review.

9.

Fibrinogen heterogeneity: inherited and noninherited.

de Maat MP, Verschuur M.

Curr Opin Hematol. 2005 Sep;12(5):377-83. Review.

PMID:
16093783
10.

Endothelial cells organize fibrin clots into structures that are more resistant to lysis.

Jerome WG, Handt S, Hantgan RR.

Microsc Microanal. 2005 Jun;11(3):268-77.

PMID:
16060980
11.

Fibrinogen and fibrin.

Weisel JW.

Adv Protein Chem. 2005;70:247-99. Review.

PMID:
15837518
12.

Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling.

Belkin AM, Tsurupa G, Zemskov E, Veklich Y, Weisel JW, Medved L.

Blood. 2005 May 1;105(9):3561-8. Epub 2005 Jan 6.

14.

[STUDY OF THE PHENOMENA OF COAGULATION AND FIBRINOLYSIS BY A SIMPLE METHOD OF CONTINUOUS OPTICAL REGISTRATION].

BOUVIER CA, GRUENDLINGER J.

Schweiz Med Wochenschr. 1963 Oct 12;93:1451-5. French. No abstract available.

PMID:
14094821
15.

The determination of plasma fibrinogen by the clot-weight method.

INGRAM IC.

Biochem J. 1952 Aug;51(5):583-5. No abstract available.

16.

Guidelines on fibrinogen assays.

Mackie IJ, Kitchen S, Machin SJ, Lowe GD; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.

Br J Haematol. 2003 May;121(3):396-404. No abstract available.

PMID:
12716361
17.

Structural origins of fibrin clot rheology.

Ryan EA, Mockros LF, Weisel JW, Lorand L.

Biophys J. 1999 Nov;77(5):2813-26.

18.

Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains.

Yokoyama K, Zhang XP, Medved L, Takada Y.

Biochemistry. 1999 May 4;38(18):5872-7.

PMID:
10231539
19.

Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin.

Bach TL, Barsigian C, Yaen CH, Martinez J.

J Biol Chem. 1998 Nov 13;273(46):30719-28.

20.

Supplemental Content

Support Center